(2019) International multicenter randomized, placebo-controlled phase III clinical trial of beta-D-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology. pp. 911-921. ISSN 1568-5608 (Electronic) 0925-4692 (Linking)